Efficacy and Safety of Tralokinumab Treatment in Adults of Different Racial Subgroups With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials. J of Skin 2023, 7 (2), s141. https://doi.org/10.25251/skin.7.supp.141.